TrademarkDir
REVANESSE
LIVE

Serial Number

88293145

Owner

Prollenium Medical Technologies, Inc.

Attorney

Cassandra L. Wilkinson

Filing Date

Feb 7, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REVANESSE Trademark

Serial Number: 88293145 • Registration: 6066727

REVANESSE is a trademark filed by Prollenium Medical Technologies, Inc. on February 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Prollenium Medical Technologies, Inc. (48 trademarks)

138 Industrial Parkway North
Aurora, Ontario L4G4C3 , CA

Entity Type: 03

Trademark Details

Filing Date

February 7, 2019

Registration Date

June 2, 2020

Published for Opposition

March 17, 2020

Goods & Services

Syringes containing hyaluronic acid gel for use in cosmetic treatment procedures and wound healing

Filing History

TEAS SECTION 8 & 15 RECEIVED
Jun 2, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 2, 2025 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 24, 2024 ASCK
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 17, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 13, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 13, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 13, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 18, 2019 RCCK
ASSIGNED TO LIE
Dec 13, 2019 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 13, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
May 13, 2019 GNSL
SUSPENSION LETTER WRITTEN
May 13, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 2, 2019 GPRN
PRIORITY ACTION E-MAILED
May 2, 2019 GPRA
PRIORITY ACTION WRITTEN
May 2, 2019 CPRA
ASSIGNED TO EXAMINER
Apr 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2019 NWOS
NEW APPLICATION ENTERED
Feb 11, 2019 NWAP

Related Trademarks

More from this Owner

VAMP

VAMP

EXOS

EXOS

EXOS

EXOS

EXOS

EXOS

REVANESSE RENEW

REVANESSE RENEW

REVANESSE RENEW

REVANESSE RENEW